Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ORMP

Oramed Pharmaceuticals Inc

Jun 10 • 04:00PM ET

3.70

+0.05 1.37 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ANTX BDTX TNYA MOLN HURA MENS MSLE OKUR PLX SPRB

| Held by: IWC DFAS DFAC AVSC DCOR AVUS DFUS DXUV

Scroll to Statements

Index	-	P/E	1.43	EPS (ttm)	2.58	Insider Own	22.75%	Shs Outstand	40.93M	Perf Week	1.37%
Market Cap	151.43M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	31.61M	Perf Month	-19.91%
Enterprise Value	86.35M	PEG	-	EPS next Q	0.15	Inst Own	37.39%	Short Float	2.09%	Perf Quarter	8.82%
Income	109.19M	P/S	-	EPS this Y	-44.96%	Inst Trans	0.20%	Short Ratio	4.20	Perf Half Y	47.54%
Sales	0.00M	P/B	0.64	EPS next Y	-	ROA	52.45%	Short Interest	0.66M	Perf YTD	39.26%
Book/sh	5.82	P/C	2.30	EPS next 5Y	-	ROE	57.61%	52W High	5.01 -26.15%	Perf Year	77.98%
Cash/sh	1.61	P/FCF	-	EPS past 3/5Y	- -	ROIC	45.73%	52W Low	1.84 100.96%	Perf 3Y	2.56%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-9.55% -5.90%	Gross Margin	-	Volatility	4.99% 6.32%	Perf 5Y	-72.57%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	480.26%	Oper. Margin	-	ATR (14)	0.23	Perf 10Y	-51.78%
Dividend Ex-Date	Jan 16, 2026	Quick Ratio	6.45	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	42.11	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.45	EPS Q/Q	592.34%	SMA20	-8.42%	Beta	1.26	Target Price	6.25
Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	-100.00%	SMA50	-5.45%	Rel Volume	1.11	Prev Close	3.65
Employees	13	LT Debt/Eq	0.00	Earnings	Jun 03	SMA200	21.84%	Avg Volume	157.08K	Price	3.70
IPO	Mar 19, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	173,612	Change	1.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)